Inspire Medical Systems topped Q3 expectations, signaling continued market strength and innovation.

Inspire Medical Systems shares are up today on third-quarter results that came in ahead of the consensus forecast.

Among potential surgeries for sleep apnea is UPPP (uvulopalatopharyngoplasty) surgery, which involves removing part of the ...

When someone has sleep apnoea, their breathing stops repeatedly during sleep. Physiologically speaking, the front wall of the ...

H.C. Wainwright analyst Edward White has reiterated their bullish stance on NYXH stock, giving a Buy rating on November 5. Edward White has ...

The technology company has filed a patent for an innovative "smart pillow" aimed at treating obstructive sleep apnea (OSA). If snoring noises are detected, air chambers change the position of the ...

Do you suffer from sleep apnea and long for a peaceful night’s sleep and solution to your snoring? Holy Cross Medical Group pulmonologist Ronald Scott, M.D. will speak about Inspire®, an FDA-approved ...

Inspire is increasing its full year 2024 revenue guidance to between $793 million to $798 million, which represents growth of 27% to 28% over full year 2023 revenue of $624.8 million. This compares to ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR and PDMA-approved neurostimulation technology of ...